Association of Obesity Phenotypes With Cognitive Impairment and Genetic Stratification Analysis in Older Chinese Adults

CHEN Xin, YAN Haiyu, ZHAO Qingwen, YANG Nan, XU Bin, LIAO Jiaqiang, JIANG Xia, LI Jiayuan

Abstract


Objective 

To evaluate the association of different obesity phenotypes and their components with the risk of cognitive impairment in older Chinese adults, and to assess the association between obesity and cognitive impairment in different cognition-related genetic backgrounds.

Methods 

A cross-sectional study based on the West China Health and Aging Cohort was conducted. Logistic regression was applied to estimate the association of obesity phenotypes and components with cognitive impairment in older Chinese adults stratified by APOE gene and polygenic risk scores.

Results 

A total of 7316 participants were enrolled, of whom 1820 had cognitive impairment. Weight gains were associated with a reduced risk of cognitive impairment (odds ratio [OR] = 0.96, 95% CI, 0.95-0.97). Being overweight with a normal waist-to-hip ratio was a protective factor for cognition (OR = 0.74, 95% CI, 0.61-0.90), whereas the coexistence of elevated waist-to-hip ratio and overweight did not increase the risk of cognitive impairment. Sarcopenia was associated with an elevated risk of cognitive impairment. This association was found in both overweight (OR = 2.03, 95% CI, 1.71-2.41) and non-overweight older adults (OR = 1.86, 95% CI, 1.58-2.20), and was significant across all polygenic risk score strata.

Conclusion 

Increasing body mass may serve as a key protective factor against cognitive decline in older adults. Having sarcopenia and obesity is associated with an elevated risk of cognitive impairment, independent of genetic susceptibility.

 

Keywords: Obesity, Lean body mass, Cognitive impairment, Polygenic risk score

 

Full Text:

PDF


References


WHO. Global status report on the public health response to dementia.(2021-09-01) [2024-02-28]. https://www.who.int/publications-detail-redirect/9789240033245.

JIA L, DU Y, CHU L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health, 2020, 5(12): e661-e671. doi: 10.1016/S2468-2667(20)30185-7.

JIA L, QUAN M, FU Y, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol, 2020, 19(1): 81-92. doi: 10.1016/S1474-4422(19)30290-X.

LIVINGSTON G, HUNTLEY J, SOMMERLAD A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 2020, 396(10248): 413-446. doi: 10.1016/S0140-6736 (20)30367-6.

PROFENNO L A, PORSTEINSSON A P, FARAONE S V. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry, 2010, 67(6): 505-512. doi: 10.1016/j.biopsych.2009.02.013.

QU Y, HU H Y, OU Y N, et al. Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev, 2020, 115: 189-198. doi: 10.1016/j.neubiorev.2020.05.012.

TOLPPANEN A M, NGANDU T, KÅREHOLT I, et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis, 2014, 38(1): 201-209. doi: 10. 3233/JAD-130698.

SMITH E, HAY P, CAMPBELL L, et al. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obesity Reviews, 2011, 12(9): 740-755. doi: 10.1111/j.1467-789X.2011.00920.x.

LI J Y, LONG L, MIAO J Q, et al. The protocol for the West China Health and Aging Cohort Study. Modern Preventive Medicine, 2023, 50(6): 961-966. doi: 10.20043/j.cnki.MPM.202210469.

YANG J, ZHU C Y, YUAN L, et al. Association between triglyceride glucose index and triglyceride glucose-obesity composite indices and the risk of ischemic heart disease. J Sichuan Univ (Med Sci), 2024, 55(5): 1123-1132. doi: 10.12182/20240960103.

FOLSTEIN M F, FOLSTEIN S E, MCHUGH P R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975, 12(3): 189-198. doi: 10.1016/0022-3956 (75)90026-6.

LI H, JIA J, YANG Z. Mini-mental state examination in elderly Chinese: a population-based normative study. J Alzheimers Dis, 2016, 53(2): 487-496. doi: 10.3233/JAD-160119.

SERRANO-POZO A, DAS S, HYMAN B T. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol, 2021, 20(1): 68-80. doi: 10.1016/S1474-4422 (20)30412-9.

KUNKLE B W, GRENIER-BOLEY B, SIMS R, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet, 2019, 51(9): 1423-1424. doi: 10.1038/s41588-019-0495-7.

CHOI S W, MAK T S H, O’REILLY P F. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc, 2020, 15(9): 2759-2772. doi: 10. 1038/s41596-020-0353-1.

CHEN L K, WOO J, ASSANTACHAI P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc, 2020, 21(3): 300-307.e2. doi: 10.1016/j. jamda.2019.12.012.

BLÜHER M. Metabolically Healthy Obesity. Endocr Rev, 2020, 41(3): bnaa004. doi: 10.1210/endrev/bnaa004.

MAHONEY F I, BARTHEL D W. Functional evaluation: the Barthel index. Md State Med J, 1965, 14: 61-65.

YESAVAGE J A, BRINK T L, ROSE T L, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res, 1982, 17(1): 37-49. doi: 10.1016/0022-3956(82)90033-4.

SPITZER R L, KROENKE K, WILLIAMS J B W, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med, 2006, 166(10): 1092-1097. doi: 10.1001/archinte.166.10.1092.

Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, Chinese Medical Doctor Association Hypertension Committee, Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, et al. 2018 Chinese guidelines for the management of hypertension. Chinese Journal of Cardiovascular Medicine, 2019, 24(1): 24-56. doi: 10.3969/j.issn.1007-5410.2019.01.002.

PAN X C. Analysis of the association between obesity genes and brain structure and exploration of causal relationship. Changchun: Jilin University, 2022. doi: 10.27162/d.cnki.gjlin.2022.000143.

SUN X Y. Study on the correlation between obesity and cognitive function-related genes and their interactions and mild cognitive impairment. Yinchuan: Ningxia Medical University, 2020. doi: 10.27258/d.cnki.gnxyc.2020.000054.

MA W B. A study on the association between obesity in the elderly and cognitive impairment. Shanghai: Shanghai University of Traditional Chinese Medicine, 2021. doi: 10.27320/d.cnki.gszyu.2021.000386. KALISH V B. Obesity in older adults. Prim Care, 2016, 43(1): 137-144, ix. doi: 10.1016/j.pop.2015.10.002.

STEVENS J, McCLAIN J E, TRUESDALE K P. Selection of measures in epidemiologic studies of the consequences of obesity. Int J Obes (Lond), 2008, 32 Suppl 3: S60-S66. doi: 10.1038/ijo.2008.88.

HAN T S, TAJAR A, LEAN M E J. Obesity and weight management in the elderly. Br Med Bull, 2011, 97: 169-196. doi: 10.1093/bmb/ldr002.

WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004, 363(9403): 157-163. doi: 10.1016/S0140-6736(03)15268-3.

LIU C, WONG P Y, CHUNG Y L, et al. Deciphering the “obesity paradox” in the elde rly: a systematic review and meta-analysis of sarcopenic obesity. Obes Rev, 2023, 24(2): e13534. doi: 10.1111/obr.13534.

IACOBINI C, PUGLIESE G, BLASETTI FANTAUZZI C, et al. Metabolically healthy versus metabolically unhealthy obesity. Metabolism, 2019, 92: 51-60. doi: 10.1016/j.metabol.2018.11.009.


Refbacks

  • There are currently no refbacks.